| Date Filed | Type | Description |
| 08/07/2023 |
4
| MAETZOLD DEREK J (Pres. & Chief Exec. Officer) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Sold 286 shares
@ $20.1, valued at
$5.7k
Sold 90 shares
@ $20.1, valued at
$1.8k
Sold 90 shares
@ $20.1, valued at
$1.8k
Sold 35 shares
@ $20.1, valued at
$703.5
Sold 33 shares
@ $20.1, valued at
$663.3
Sold 33 shares
@ $20.1, valued at
$663.3
Sold 33 shares
@ $20.1, valued at
$663.3 |
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/02/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Caple Kim (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 440 restricted stock units
@ $0 |
|
| 07/11/2023 |
4
| MAETZOLD DEREK J (Pres. & Chief Exec. Officer) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Sold 8,376 shares
@ $20.044, valued at
$167.9k
Sold 4,188 shares
@ $20.044, valued at
$83.9k
Sold 4,188 shares
@ $20.044, valued at
$83.9k
Sold 2,091 shares
@ $20.044, valued at
$41.9k
Sold 2,091 shares
@ $20.044, valued at
$41.9k
Sold 2,091 shares
@ $20.044, valued at
$41.9k
Sold 2,091 shares
@ $20.044, valued at
$41.9k
|
|
| 07/11/2023 |
4
| BRADBURY DANIEL (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Sold 30,000 shares
@ $20.39, valued at
$611.7k
Sold 10,000 shares
@ $20.39, valued at
$203.9k
Sold 10,000 shares
@ $20.39, valued at
$203.9k
|
|
| 07/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
4
| Goldberg Ellen (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Bought 2,300 shares
@ $11.23, valued at
$25.8k
Bought 2,500 shares
@ $17.27, valued at
$43.2k
|
|
| 06/06/2023 |
4
| Caple Kim (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| BRADBURY DANIEL (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| Aspinall Mara G. (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| Cole G Bradley (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| Goldberg Ellen (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| Harrison Miles (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/06/2023 |
4
| Olson Tiffany (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 3,825 restricted stock units
@ $0 |
|
| 06/01/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/30/2023 |
4
| Olson Tiffany (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Granted 8,636 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| Harrison Miles (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Granted 8,636 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| Goldberg Ellen (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Granted 8,636 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| Cole G Bradley (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Granted 8,636 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| Caple Kim (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Granted 8,636 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| BRADBURY DANIEL (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Granted 8,636 restricted stock units
@ $0 |
|
| 05/30/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2023 |
4
| MAETZOLD DEREK J (Pres. & Chief Exec. Officer) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Sold 1,538 shares
@ $23.447, valued at
$36.1k
Sold 769 shares
@ $23.447, valued at
$18k
Sold 769 shares
@ $23.447, valued at
$18k
Sold 384 shares
@ $23.447, valued at
$9k
Sold 384 shares
@ $23.447, valued at
$9k
Sold 384 shares
@ $23.447, valued at
$9k
Sold 384 shares
@ $23.447, valued at
$9k
Sold 1,254 shares
@ $22.82, valued at
$28.6k
Sold 627 shares
@ $22.82, valued at
$14.3k
Sold 627 shares
@ $22.82, valued at
$14.3k
Sold 313 shares
@ $22.82, valued at
$7.1k
|
|
| 05/15/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/12/2023 |
4
| Olson Tiffany (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Exercised 487 restricted stock units
@ $0 |
|
| 05/08/2023 |
4
| BRADBURY DANIEL (Director) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Sold 3,400 shares
@ $21.289, valued at
$72.4k
Sold 1,134 shares
@ $21.289, valued at
$24.1k
Sold 1,133 shares
@ $21.289, valued at
$24.1k
Sold 7,185 shares
@ $21.879, valued at
$157.2k
Sold 2,395 shares
@ $21.879, valued at
$52.4k
Sold 2,396 shares
@ $21.879, valued at
$52.4k
Sold 2,039 shares
@ $21.117, valued at
$43.1k
Sold 679 shares
@ $21.117, valued at
$14.3k
Sold 680 shares
@ $21.117, valued at
$14.4k
Sold 2,376 shares
@ $21.804, valued at
$51.8k
Sold 792 shares
@ $21.804, valued at
$17.3k
|
|
| 05/08/2023 |
4
| MAETZOLD DEREK J (Pres. & Chief Exec. Officer) has filed a Form 4 on CASTLE BIOSCIENCES INC|
Txns:
| Sold 1,660 shares
@ $21.428, valued at
$35.6k
Sold 830 shares
@ $21.428, valued at
$17.8k
Sold 830 shares
@ $21.428, valued at
$17.8k
Sold 414 shares
@ $21.428, valued at
$8.9k
Sold 415 shares
@ $21.428, valued at
$8.9k
Sold 414 shares
@ $21.428, valued at
$8.9k
Sold 414 shares
@ $21.428, valued at
$8.9k
Sold 1,132 shares
@ $21.943, valued at
$24.8k
Sold 566 shares
@ $21.943, valued at
$12.4k
Sold 566 shares
@ $21.943, valued at
$12.4k
Sold 283 shares
@ $21.943, valued at
$6.2k
|
|
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/03/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|